No Carolina / NY / Florida       

      Ph: 561.316.3330

Todd Lanman MD Announces Completion of First Lumbar Total Joint Replacement Procedure in California as Part of a Clinical Trial

What To Know

  • I can already do this in the neck and in some cases in the low back, but with MOTUS I can take care of people earlier in the disease process and more completely.
  • He is recognized throughout the world as a pioneer in motion surgery for the spine, with a unique practice including A-list celebrities, musicians, luminaries, C-suite executives and foreign dignitaries, many of whom travel the globe to seek his unique approach to care.

Todd Lanman MD and Lanman Spinal Neurosurgery announced completion of the first lumbar total joint replacement procedure in California as part of a pivotal clinical trial sponsored by 3Spine, Inc. The surgery was performed on an outpatient basis at the Advanced Surgery Center of Beverly Hills. MOTUS, the implant used in the procedure, received Breakthrough Device Designation from the U.S. Food and Drug Administration in 2020 and is currently approved for use at up to 20 U.S. centers under an Investigational Device Exemption.

The study sponsor selected Dr. Lanman as the California site based on his significant contributions to motion technology research. He is recognized throughout the world as a pioneer in motion surgery for the spine, with a unique practice including A-list celebrities, musicians, luminaries, C-suite executives and foreign dignitaries, many of whom travel the globe to seek his unique approach to care. Dr. Lanman’s Restorative Motion Surgery philosophy focuses on retention of natural range of motion; physical conditioning; and a return to full, long-term function.

“We have proven that we can retain movement with artificial disc replacement surgery and can even reverse past fusions,” said Tom Lanman MD “The century-old ‘go-to’ procedure of fusing the spine should be a thing of the past. We strongly believe that at least half of fusions in the U.S. should never have been done in the first place. Every other joint in the body gets a replacement, and the spine should be no different.”

Dr. Lanman continued, “We always ask the question somewhat rhetorically, ‘What surgery would you want for yourself or a loved one?’ Can anyone honestly say they would want a spinal fusion? I’ve personally had eleven spine surgeries. I have one artificial disc in my neck, three in my back, and two fused levels in my lower lumbar spine. So that’s your answer. I’m a spine surgeon and I chose motion. The only reason we aren’t using joint replacements in every case is we just don’t have every implant we need. I think MOTUS will change that. If this clinical trial is successful, I can take care of maybe 80% of all degenerative lumbar patients with leg and back pain, including people with severe stenosis, worn out facets, bad discs, and instability. I can already do this in the neck and in some cases in the low back, but with MOTUS I can take care of people earlier in the disease process and more completely. This is very exciting.”

3Spine’s lumbar total joint replacement procedure and MOTUS device is a ‘first-of-kind’ technology replacing the function of the disc and facet joints through a posterior approach. The procedure is intended to broadly address leg pain, back pain and spinal instability while correcting posture and movement. Much like a hip or knee total joint replacement, the procedure treats degenerative disease through reconstruction of the functional spinal unit.

3Spine, Inc. is seeking single-level indications from L1-S1 in patients suffering from lumbar degeneration with or without foraminal or recess spinal stenosis with no more than a grade 1 spondylolisthesis at the involved level. Additional details are available at ClinicalTrials.gov. Patients in the Greater Los Angeles area interested in participating in the clinical trial can email Nicole at research@spine.md for more information.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More

Advertise wiith Medical Device News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy